Premium
Pharmacogenomic Testing: Knowing More, Doing Better
Author(s) -
Lunshof J E,
Gurwitz D
Publication year - 2012
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.2011.339
Subject(s) - pharmacogenomics , clinical pharmacology , thriving , pharmacogenetics , clinical practice , medical education , medicine , psychology , pharmacology , family medicine , genotype , biology , biochemistry , psychotherapist , gene
The clinical uptake of pharmacogenomic (PGx) testing and genotype‐based prescribing has been disappointingly slow even though research on PGx is thriving. A recent survey on the adoption of PGx testing by US physicians suggests that this trend may start changing for the better. 1 Acquiring more knowledge of PGx tests and their clinical significance during graduate and postgraduate education will enable physicians to make better use of the available and upcoming PGx diagnostics in clinical practice. Clinical Pharmacology & Therapeutics (2012); 91 3, 387–389. doi: 10.1038/clpt.2011.339